Search Within

Hematology-Oncology Fellows

  1. "Sarcoma Service"
Formats
  1. Meeting Abstract (24)
  2. Journal Article (13)
  3. Research Letter (2)
  4. Correspondence (1)
  5. Review (1)
Groups
  1. Department of Medicine (41)
  2. Sarcoma Service (41)
  3. Solid Tumor Oncology Division (41)
  4. Weinberg Fellows (28)
  5. Hematologic Malignancies, Division of (24)
  6. GSK Faculty (23)

More Groups

People
  1. Viswatej Avutu (27)
  2. William Tap (27)
  3. Mrinal Gounder (24)
  4. Sandra D'Angelo (22)
  5. Ciara Kelly (21)
  6. Mark Dickson (20)

More People

Years
  1. 2025 (3)
  2. 2024 (11)
  3. 2023 (9)
  4. 2022 (12)
  5. 2021 (1)
  6. 2020 (5)
Publications
  1. Journal of Clinical Oncology (20)
  2. Annals of Oncology (5)
  3. Journal of Adolescent and Young Adult Oncology (3)
  4. Clinical Cancer Research (2)
  5. Cancer Research Communications (1)
  6. Cancers (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (20)
  2. Oxford University Press (6)
  3. American Association for Cancer Research (3)
  4. Mary Ann Liebert, Inc (3)
  5. Amer Assoc Advancement Science (1)
  6. American Medical Association (1)

More Publishers

Results (41)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Redefining early-onset cancer and risk of hereditary cancer predisposition
    Meeting Abstract

    Stadler, Z. K.; Maio, A.; Khurram, A.; Kemel, Y.; Padunan, A.; Borio, M.; Sheehan, M.; Murciano-Goroff, Y. R.; Walsh, M. F.; Will, M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Journal Article

    Kelly, C. M.; Qin, L. X.; Whiting, K. A.; Richards, A. L.; Avutu, V.; Chan, J. E.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer
    Journal Article

    Li, D.; Zhan, Y.; Wang, N.; Tang, F.; Lee, C. J.; Bayshtok, G.; Moore, A. R.; Wong, E. W. P.; Pachai, M. R.; Xie, Y.; more...
    Science Advances (2023)

    Fulltext@MSK | Save
  • A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma
    Meeting Abstract

    Slotkin, E. K.; Mauguen, A.; Ortiz, M. V.; Dela Cruz, F. S.; O'Donohue, T.; Kinnaman, M. D.; Meyers, P. A.; Wexler, L. H.; Rodriguez, S.; Avutu, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase I/II trial of the PD-1 inhibitor retifanlimab (R) in combination with gemcitabine and docetaxel (GD) as first-line therapy in patients (Pts) with advanced soft-tissue sarcoma (STS)
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Thornton, K. A.; Movva, S.; Nacev, B. A.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Avutu, V.; Chi, P.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Movva, S.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Nacev, B. A.; Rosenbaum, E.; Thornton, K. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Presence of immune infiltrates, increased expression of transposable elements, and viral response pathways in sarcoma associate with response to checkpoint inhibition
    Meeting Abstract

    Nacev, B. A.; Bradic, M.; Richards, A. L.; Kelly, C. M.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Chi, P.; Movva, S.; Thornton, K. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development
    Meeting Abstract

    Liu, D.; Murciano-Goroff, Y. R.; Jee, J.; Arcila, M. E.; Buonocore, D. J.; Gao, J.; Chakravarty, D.; Schram, A. M.; Callahan, M. K.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase 1/2 dose-escalation and dose-expansion study of ZN-c3 in combination with gemcitabine in adult and pediatric subjects with relapsed or refractory osteosarcoma
    Meeting Abstract

    Avutu, V.; Slotkin, E. K.; Livingston, J. A. A.; Chawla, S. P.; Pressey, J. G.; Nandkumar, P.; Zheng, C.; Misir, S.; Pultar, P.; Voliotis, D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • The role of immunotherapy in the management of soft tissue sarcomas: Current landscape and future outlook
    Review

    Banks, L. B.; D'Angelo, S. P.
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save